Kendal Kloiber

For decades, innovation in spine focused on improving implants, refining surgical techniques and increasing fusion rates. While those goals remain important, today’s advances are shifting the conversation beyond simply achieving successful fixation. Increasingly, implant manufacturers are developing technologies designed to minimize tissue disruption, improve implant fixation and create a more favorable environment for bone healing — all while allowing surgeons to perform less invasive procedures.

Subscribe today to listen to this content Get Access For ACL patients, the first year after reconstruction is a balancing act. Push too little, and you risk stiffness, weakness and a sluggish return to sport. Push too hard…well, that’s been less clear. A new study in Medicine & Science in Sports & Exercise suggests the answer might not be as reassuring as many would hope: More activity early on may feel good — but it could quietly be nudging the knee toward osteoarthritis.

Subscribe today to listen to this content Get Access When it comes to treating rotator cuff tendinopathy, corticosteroid injections have long been the orthopedic equivalent of a fast-acting painkiller: quick relief, predictable response, and widely accessible. Platelet-rich plasma (PRP), on the other hand, has occupied a murkier space — promising, debated and often dismissed as inconsistent.